Merck | MRK - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Abbott USD 2.43B 844M 2026-03
ALKERMES USD 120.06M 19.15M 2026-09
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Drreddys Laboratories INR 18.79B 10.16B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
J&J USD 8.99B 721M 2026-06
Medtronic USD 2.63B 174M 2026-06
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Novo Nordisk DKK 37.36B 2.64B 2026-06
Pacira USD 50.45M 1.78M 2026-09
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 89.44M 28.2M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sanofi EUR 6.66B 4.99B 2026-09
United Therapeutics USD 334.2M 20.8M 2026-09
Zoetis USD 1.07B 21M 2026-09